核醫(yī)學(xué)和生物學(xué)旨在為描述原始合成、體外組織研究或體內(nèi)使用放射性示蹤劑、放射性藥物或治療劑的原始研究貢獻(xiàn)。論文集中于合成、體外試驗(yàn)和體內(nèi)化合物的檢測(cè)。廣泛的研究證明了在體內(nèi)定位的機(jī)制，無(wú)論是基于受體，酶，或腫瘤抗原結(jié)合或其他明確定義的過(guò)程是每一個(gè)評(píng)估的一個(gè)組成部分。此外，研究應(yīng)確定一個(gè)重要的化合物，是一個(gè)敏感的探針的生化變化在體內(nèi)。

Nuclear Medicine and Biology is intended for original research contributions describing original synthesis, in vitro tissue studies, or in vivo use of radiotracers, radiopharmaceuticals, or therapeutic agents. Papers concentrate on the synthesis, testing in vitro, and examination of a compound in vivo. Extensive studies proving the mechanism of localization in vivo whether the radioactive substance is based on receptor-, enzyme-, or tumor antigen-binding or other well defined processes are an integral part of each evaluation. Additionally, studies should define a significant compound that is a sensitive probe of a biochemical change in vivo.